However, some peptides, such as semaglutide and tirzepatide, are FDA-approved for weight loss under brand names Wegovy and Zepbound, respectively
Standard Dosing Parameters Primary Application Dosing 1-2 mg daily 2-3 mg daily or 2 mg 2-3x per week 1-2 mg daily (injectable or topical) 2-5 mg daily under medical supervision Clinical studies used 0.3 mg/mL injections, while systemic wound healing in animal studies used approximately 1.1 mg/kg body weight (translating to ~75 mg total for humans in divided doses)
You are responsible for confirming identity, suitability, compatibility, and handling requirements before use
The formulation is stabilized using excipients such as citric acid, mannitol, and polysorbate 80, while an automated needle mechanism facilitates self-injection by extending and retracting the needle, thereby improving patient adherence and ease of use
Supporting Study: Themmen, A